Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Global and Indian Trends in Polycystic Ovary Syndrome: Epidemiology and Therapeutic Perspectives

Journal Submission Sample Work

Polycystic Ovary Syndrome (PCOS) is a common endocrine and metabolic disorder affecting women of reproductive age. It is characterised by hormonal imbalance, irregular ovulation, hyperandrogenism, and ovarian abnormalities, leading to complications such as infertility, insulin resistance, obesity, and metabolic disorders.

PCOS is an increasing global and Indian health concern due to changing lifestyles and rising prevalence. Advances in diagnosis and treatment have improved management through lifestyle modification, hormonal therapies, metabolic interventions, and fertility-focused approaches.

This article discusses global and Indian PCOS trends, associated risk factors, clinical features, and emerging therapeutic strategies for improving women’s reproductive and long-term health.

Why PCOS prevalence figures vary, and why that shapes the target journal

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. It is usually diagnosed using the Rotterdam criteria, which require two of three features: irregular or absent ovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound. Because older definitions demanded different combinations, prevalence estimates depend heavily on which criteria a study used — the appendix of this sample puts global prevalence at roughly 6–20% of women for exactly that reason. In India, reported rates differ across regions and populations, and the condition is increasingly recognised alongside rising obesity and insulin resistance.

A review titled Global and Indian Trends in Polycystic Ovary Syndrome: Epidemiology and Therapeutic Perspectives therefore spans reproductive endocrinology, metabolic medicine and women's health. Its fourteen keywords run from prevalence and the Indian population to hyperandrogenism, infertility, lifestyle modification and assisted reproductive technology. The journal selection report has to find journals that will accept a paper moving between epidemiology and treatment.

From ovarian biology to general gynaecology: a three-tier shortlist

The three journals recommended in the report sit at different distances from the topic, which gives the author a genuine choice of audience.

  • Journal of Ovarian Research (BioMed Central) is the specialist option, described as the only journal covering all aspects of ovarian research. One of its cited examples deals directly with ovarian inflammation and hormonal dysregulation as a candidate mechanism underlying PCOS.
  • Human Reproduction (Oxford University Press) is the reproductive-medicine option, whose scope runs from reproductive endocrinology and infertility treatment to genetics and ethics. Its examples concern embryo transfer practice and immune profiling in endometriosis, showing a clinical-fertility emphasis.
  • International Journal of Gynecology & Obstetrics (Wiley) is the broadest choice, with emphasis on matters of worldwide interest — relevant for a paper with a global-versus-Indian comparison. Its examples include a study of thyroid function and hypertensive disorders of pregnancy.

A supporting table gives each journal a one-line rationale and a scope statement; the Journal of Ovarian Research scope explicitly lists polycystic ovary syndrome, infertility and assisted reproductive technologies.

Working with the comparator when some fields say "not mentioned"

The comparator records the parameters below, all as reported in the sample; impact factors and charges should be checked again before submission because they change each year.

  • Impact factor: 5.3 (Journal of Ovarian Research), 6.8 (Human Reproduction), 2.7 (IJGO).
  • Review duration: 6 weeks; 4–6 weeks; 7–8 days.
  • Rejection rate: not mentioned; 70–80%; 75%.
  • APC: USD 3,490; not mentioned; USD 4,480 for open-access publication.
  • Word count: no strict limit; 3,000–4,000 words; 2,500–4,000 words.
  • References: no fixed maximum; 50–100; no limit.

Several cells are recorded as not mentioned, and the report leaves them that way instead of guessing — the right approach, since an invented acceptance rate is worse than an honest gap. For Human Reproduction, the missing APC usually reflects a subscription journal with an optional open-access route; authors should confirm the fee, if any, with the publisher. The very short review time reported for IJGO is likely to describe an initial editorial screen rather than full peer review.

An appendix written about the condition itself

Unlike many journal reports, whose closing questions concern the journals, this sample ends with five questions about PCOS: what it is, how common it is globally and in India, its symptoms, its causes and how it is diagnosed and treated. The answers describe irregular cycles, hirsutism, acne, weight gain and insulin resistance, and an individualised approach combining lifestyle change, weight management and medicines for cycle regulation, insulin sensitivity and fertility. This makes the document readable for co-authors outside gynaecology, such as epidemiologists or nutrition researchers. As with any writing sample, this material is illustrative and is not medical advice.

Adapting the PCOS report to a manuscript of your own

The report is useful as a model because the three journals are genuinely different, not three versions of the same choice. Authors adapting it should check that the cited example papers are close to their own topic — the PCOS-mechanism paper is a strong example, an ovarian-cancer delivery paper less so — and that length limits suit the manuscript before drafting, since a 2,500-word ceiling would force a much shorter review than a journal with no strict limit. Pubrica's journal selection service prepares reports of this kind, while manuscript formatting adapts the paper to the chosen journal's author guidelines. A review that needs a stronger synthesis of Indian prevalence studies can be supported through literature review and gap analysis.

Questions about this sample

Which journal in the PCOS report is the most specialised?

The Journal of Ovarian Research, published by BioMed Central. The report describes it as the only journal covering all aspects of ovarian research, and its scope explicitly includes polycystic ovary syndrome. It also cites a recent article from the journal on ovarian inflammation and hormonal dysregulation as a possible mechanism in PCOS.

Why does the sample quote a wide global prevalence range for PCOS?

The appendix gives approximately 6 to 20 percent because prevalence depends on the diagnostic criteria used. Definitions requiring hyperandrogenism and anovulation produce lower estimates than the Rotterdam criteria, which also accept polycystic ovarian morphology. Indian studies vary further by region and population, so a review must state which definitions its sources applied.

What should authors do about the fields marked not mentioned?

Treat them as gaps to verify, not as zero. The sample leaves the rejection rate and APC for some journals unrecorded rather than estimating them. Before submitting, authors should consult each journal's author guidelines and publisher pages for current charges, open-access options and turnaround statistics, since all of these change over time.

Is Human Reproduction suitable for an epidemiology-focused review?

It can be, provided the review links prevalence trends to clinical implications such as infertility and assisted reproduction, which sit at the centre of the journal's scope. As reported in the sample it has a 3,000 to 4,000 word limit and a 70 to 80 percent rejection rate, so the review would need a clear, focused argument.

pubrica services with experts

Research your Services with our experts

Delivered on-time or your money back

Give yourself the academic edge today

Each order includes

  • On-time delivery or your money back
  • A fully qualified writer in your subject
  • In-depth proofreading by our Quality Control Team
  • 100% confidentiality, the work is never re-sold or published
  • Standard 7-day amendment period
  • A paper written to the standard ordered
  • A detailed plagiarism report
  • A comprehensive quality report

Enquire Now

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.